Finally, a set of promising compounds were highlighted as potential SIRT1 activators (Figure 7(Fig. 7)) to be further developed for Alzheimer's disease, other aging diseases, and other relevant therapeutics. Here, SIRT1 is linked to early-onset autosomal dominant Alzheimer disease.